Panel Discussion: Exploring the Untapped Potential of AI in Spatial Omics & Digital Pathology to Advance Highly Accurate, Time & Cost Effective Analysis

3:30 pm - Thursday 26th March 2026

  • Strategizing the applications of AI for cell phenotyping, scoring biomarkers, evaluating protein interactions
  • Evaluating available technologies and selecting appropriate tools based on research aims and project priorities
  • Training algorithms sufficiently and shedding light on the ‘black box’to increase implementation of AI across workflows

Speakers:

Executive Director
Amgen
Principal Scientist - Bioinformatics
Abbvie
Assistant Professor & Scientific Founder
California Institute of Technology & Alzen Therapeutics
Director - Pathobiology
Gilead